STAGE IVA HEPATOCELLULAR CARCINOMA

Clinical trials for STAGE IVA HEPATOCELLULAR CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new STAGE IVA HEPATOCELLULAR CARCINOMA trials appear

Sign up with your email to follow new studies for STAGE IVA HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Double attack on advanced liver cancer shows promise

Disease control Completed

This study tested whether using two drugs together works better than one for treating advanced liver cancer that has spread. The trial combined sorafenib, a pill that blocks cancer cell growth, with pembrolizumab, an IV drug that helps the immune system fight cancer. It involved …

Matched conditions: STAGE IVA HEPATOCELLULAR CARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control

Last updated Apr 02, 2026 04:12 UTC

STAGE IVA HEPATOCELLULAR CARCINOMA

Get alerted when new STAGE IVA HEPATOCELLULAR CARCINOMA trials appear

Double attack on advanced liver cancer shows promise